More recently, in 2015, Dhyani et al. performed a chromatin immunoprecipitation (ChIP) analysis, showing that ANKHD1 was also localised within the nucleus, where it associates with DNA to repress the p21 promoter by directly binding to it in a multiple myeloma cell line. Here, ANKHD1 is linked to plasma cell myeloma.